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Original article
Radiation exposure awareness from patients undergoing 
nuclear medicine diagnostic 99mTc-MDP bone scans and 
2-deoxy-2-(18F) fluoro-D-glucose PET/computed tomography 
scans
Ana S.F. Ribeiroa, Olga Hussonb, Nicholas Dreyc, Iain Murraya,  
Katherine Maya, Jim Thurstona and Wim J.G. Oyena,b  
Introduction Medical imaging is on average the 
largest source of artificial radiation exposure worldwide. 
This study seeks to understand patient’s awareness 
of radiation exposure derived from nuclear medicine 
diagnostic scans and assess if current information 
provided by leaflets is adequate.
Methods Single-centre cross-sectional questionnaire 
study applied to bone scan and FDG PET/computed 
tomography patients, at a nuclear medicine and PET/
computed tomography department over a 15-week period 
in 2018. Questionnaires on dose comparators were 
designed in collaboration with patients, public, and experts 
in radiation exposure. Qualitative data were analysed using 
thematic analysis and quantitative data using SPSS (V. 24).
Results A total of 102 questionnaires were completed 
(bone scan = 50; FDG PET/computed tomography = 52). 
Across both groups, 33/102 (32.4%) patients reported 
having a reasonable understanding of nuclear medicine 
and 21/102 (20.6%) reported a reasonable knowledge of 
ionising radiations. When asked to compare the exposure 
dose of respective scans with common comparators 
8/50 (16%) of bone scan patients and 11/52 (21.2%) 
FDG PET/computed tomography answered correctly. On 
leaflet information, 15/85 (17.6%) patients reported the 
leaflets do not provide enough information on radiation 
exposure and of these 10/15 (66.7%) commented the 
leaflets should incorporate more information on radiation 
exposure dose.
Conclusion More observational and qualitative 
studies in collaboration with patients are warranted 
to evaluate patients’ understanding and preferences 
in communication of radiation exposure from nuclear 
medicine imaging. This will ensure communication tools 
and guidelines developed to comply with ionising radiation 
(medical exposure) regulation 2017 are according to 
patients needs and preferences. Nucl Med Commun XXX: 
000–000 Copyright © 2020 The Author(s). Published by 
Wolters Kluwer Health, Inc.
Nuclear Medicine Communications 2020, XXX:000–000
Keywords: awareness, ionising radiation, nuclear medicine,  
patient engagement
aThe Royal Marsden Hospital NHS Foundation Trust, bInstitute of Cancer 
Research, Sutton and cCity, University of London, London, UK
Correspondence to Ana S.F. Ribeiro, MSc, BSc, The Royal Marsden NHS 
Foundation Trust. SM2 5PT Sutton, Surrey, United Kingdom
Tel: +004402086613900; e-mail: ana.ribeiro@nhs.net
Received 2 December 2019 Accepted 12 February 2020
 
Introduction
Worldwide, medical exposure is the highest source of 
artificial radiation, and after natural sources are the sec-
ond-largest source of exposure, accounting for 20% of the 
total exposure [1]. In nuclear medicine imaging, some 
inherent risks derive from exposure to the ionising radi-
ation that these techniques use, however, these risks are 
balanced or outweighed by the benefits to health of the 
individual according to the two principles in radiation 
protection, justification, and optimisation [2]. Justification 
ensures the procedure is necessary, justifiable, and the 
benefits outweigh the risks. Optimisation ensures that 
all practical measures are in place to reduce unnecessary 
exposure and risk to both the patient and the operator.
Informing patients of the levels of ionising radiation 
exposure associated with medical imaging procedures 
together with the risks and benefits is fundamental 
to comply with current UK legislation as per ionising 
radiation (medical exposure) regulations 2017 (IR(ME)
R 2017)[3] but also to enable patient decision-making, 
improve acceptance of diagnostic scans and confidence 
in the medical care received.
Describing and explaining radiation exposure and asso-
ciated risks can, however, be challenging. This is mainly 
due to patient’s background knowledge of radiation and 
health literacy levels that can vary greatly. The information 
presented to patients may not be meaningful [2]. Detailed 
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information on radiation exposure from diagnostic imaging 
can also lead to unwanted effects such as increased anxiety 
levels in patients who request additional information [4].
Lack of communication on radiation exposure can also 
derive from lack of awareness and knowledge from 
healthcare professionals, including physicians, radiogra-
phers, and nuclear medicine technologists. The results of 
recent studies results[5–10] and a systematic review of 14 
peer-reviewed articles in 2013 also demonstrated a lack of 
physician’s knowledge and a tendency to underestimate 
ionising radiation exposure from medical imaging [9].
Our recent review conducted to identify existing liter-
ature on radiation exposure awareness of patients when 
undergoing nuclear medicine diagnostic scans concluded 
that across medical imaging there is a lack of knowledge 
from patients. In addition, there is a general underesti-
mation from health professionals on ionising radiation 
exposure with a need for improvement in communica-
tion between professionals and patients [11].
The main objective of this study was to establish if patients 
understand how much radiation they are exposed to when 
they undergo two of the most common nuclear medicine 
procedures performed in the department where this study 
was conducted and if current leaflets provide adequate 
information. The procedures are bone scans and 2-deoxy-
2-(18F) fluoro-D-glucose (18F-FDG) PET/computed 
tomography scans (PET/CT). The results aim to influence 
the modification of information leaflets and improve com-
munication between healthcare professionals and patients 
regarding ionising radiation in medical imaging.
Methods
This cross-sectional questionnaire study was performed 
at the Royal Marsden NHS Foundation Trust. The study 
was conducted in accordance with HRA approval pro-
cesses. REC approval was received on 30 January 2018 
(REC reference 18/NS/0008) and HRA approval (IRAS 
project ID 233911) was received on 6 February 2018.
Questionnaire
A review of existing validated questionnaires did not find 
a suitable tool. A detailed questionnaire to identify prior 
knowledge in nuclear medicine and of ionising radiation 
used in nuclear medicine by comparing the diagnostic 
procedures with common comparators[12,13] was devel-
oped iteratively in collaboration with co-investigators, 
three patient representatives, a Radiation Protection 
Adviser, an epidemiologist and a physicist. The ques-
tionnaire was tested within the institutional nuclear 
medicine department, which included technologists, 
radiographers, specialist nurses, and physicists. Modified 
questionnaires for radiation awareness comparators 
were designed according to groups. Group 1: patients 
attending for a 99mTc-MDP bone scan; group 2: patients 
attending for an 18F-FDG PET/CT. Questionnaires 
had a brief introduction followed by four sections, (a) 
demographic questions (sex, age, education, and health 
literacy); (b) patient self-reported knowledge (e.g. Do 
you understand how nuclear medicine is used in medical diag-
nosis?); (c) patient awareness, with four questions that 
compared the doses of radiation from the two diagnos-
tic scans to natural background radiation, chest X-rays, 
CT scans, and transatlantic flights (e.g. What do you think 
a bone scan is equivalent to in terms of natural background 
radiation?); and (d) two open-ended questions on cur-
rent suitability of patient information leaflets and further 
comments, in order to complement and enrich the quan-
titative data collected. Full questionnaires can be seen 
in Supplementary Appendix 1, Supplemental digital con-
tent 1, http://links.lww.com/NMC/A164 and leaflet con-
tent in Supplementary Appendix 2, Supplemental digital 
content 2, http://links.lww.com/NMC/A165.
Participants
Purposive sampling was applied, with participants 
over the age of 18 recruited from a Nuclear Medicine 
Department that performs a variety of diagnostic and 
therapeutic procedures, mainly to an oncological popula-
tion. This descriptive study did not test any hypotheses 
and so no formal sample size calculations were performed. 
With 50 participants in each of groups 1 and 2, proportions 
within each group can be reported with 95% confidence 
intervals of not more than ± 14%. Recruitment took place 
from 26 February 2018 to 6 June 2018.
Data analysis
Quantitative data
Data were analysed using IBM SPSS Statistics 24. 
Responses to questionnaires were reported using sum-
mary descriptive statistics with assessment of differences 
between groups performed using the Chi-square tests 
(and Fisher’s exact) for categorical variables and Mann–
Whitney U test for non-parametric scale/ordinal variables, 
assuming significance at P < 0.05. Missing data checked 
using IBM SPSS Missing Value Analysis.
Qualitative data
Data from the two open-ended questions were ana-
lysed using the model proposed by Braun and Clarke 
[14]. This systematic and rigorous method involves six 
phases, resulting in final themes that describe the data 
and are supported by extracts of patient’s comments and 
views. The first question aimed to capture more in depth 
information on patient’s views of the leaflet, the second 
question was general and broader where patients could 
express any additional views, comments or concerns, as 
typically included in questionnaires.
Results
Quantitative data
A total of 102 completed questionnaires with G1 n 
= 50 and G2 n = 52 were collected and analysed. Data 
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distribution for G1, G2, and combined G1 and G2 were 
not normally distributed, and variable age was missing 
for 11 cases (10.8%) and education for two cases (2%). 
Patient characteristics are presented in Table 1.
Within G1 31/50 (62%) patients were male and 19/50 
(38%) were female with a median age of 72 (range: 63–
80). Half the patients reported having some or limited 
understanding of nuclear medicine and 19/50 (38%) some 
knowledge of radiation doses used in nuclear medicine. 
The main sources of information for patients were through 
hospital/GP leaflets 22/31 (71%), followed by discussion 
with medical staff 15/31 (48.4%). The best comparator for 
doses of radiation used in bone scans were, chest X-rays 
17/49 (34.7%) followed by natural background radiation 
14/49 (28.6%), while 12/49 (24.5%) patients were not sure 
on the best comparator to use.
G2 had 30/52 (57.7%) male and 22/52 (42.3%) female 
patients, with a median age of 66 (range: 46–72). 
Approximately half the patients 25/52 (48%) reported 
some understanding of nuclear medicine and 19/52 (37%) 
some understanding in radiation doses used in nuclear 
medicine. Patients mainly received information from 
hospital/GP 18/27 (66.7%) and 15/27 (55.6%) via discus-
sion with medical staff. As to preferences for best com-
parator to use, 23/51 (45.1%) patients reported not being 
sure of the best comparator to use with a patient adding 
under other: ‘the more information the better,’ followed 
by 10/51 (19.6%) patients preferring chest X-rays as a 
comparator.
Patient awareness and understanding of exposure to ion-
ising radiation derived from bone scans and FDG PET/
CT scans were assessed in section (c) (Q10-Q13) (Fig. 1). 
Across all four questions, 8/50 (16%) of patients from G1 
answered correctly with 9/200 (4.5%) correct answers. 
The majority of patients answered, ‘I don’t know’ 123/200 
(61.5%), followed by incorrect answers 68/200 (34%). All 
patients who answered correctly received information 
from hospital/GP leaflets and through discussion with 
Table 1 Patient characteristics
Patient characteristics
Group 1 Group 2
Combined groupsBone scan (% within group) FDG PET/CT (% within group)
Gender (Q1)
 Male 31 (n = 50; 62%) 30 (n = 52; 57.7%) 61 (59.8%)
 Female 19 (n = 50; 38%) 22 (n = 52; 42.3%) 41 (40.2%)
Age (Q2)
 Group 1 (19–59) 6 (n = 43; 14%) 17 (n = 48; 35.4%) 23 (25.3%)
 Group 2 (60–68) 12 (n = 43; 27.9%) 11 (n = 48; 22.9%) 23 (25.3%)
 Group 3 (69–75) 11 (n = 43; 25.6%) 13 (n = 48; 27.1%) 24 (26.4%)
 Group 4 (76–88) 14 (n = 43; 32.6%) 7 (n = 48; 14.6%) 21 (23.1%)
Education (Q3)
 No education 1 (n = 50; 2%) 0 1 (1%)
 Secondary school 22 (n = 50; 44%) 21 (n = 50; 42%) 43 (43%)
 Vocational qualification 4 (n = 50; 8%) 3 (n = 50; 6%) 7 (7%)
 College/Diploma 12 (n = 50; 24%) 6 (n = 50; 12%) 18 18%)
 University/Degree 10 (n = 50; 20%) 17 (n = 50; 34%) 27 (27%)
Health literacy (confidence in completing medical forms) (Q4)
 Very 30 (n = 50; 60%) 25 (n = 52; 48.1%) 55 (53.9%)
 Quite 14 (n = 50; 28%) 22 (n = 52; 42.3%) 36 (35.3%)
 Somewhat 4 (n = 50; 8%) 4 (n = 52; 7.7%) 8 (7.8%)
Understanding of nuclear medicine (Q7)
 Good/reasonable understanding 18 (n = 50; 36%) 15 (n = 52; 28.8%) 33 (32.4%)
 Some/limited understanding 25 (n = 50; 50%) 25 (n = 52; 48.1%) 50 (49%)
 No knowledge/understanding 7 (n = 50; 14%) 12 (n = 52; 23%) 19 (18.6%)
Knowledge on doses of radiation used in nuclear medicine (Q8)
 Good/reasonable understanding 12 (n = 50; 24%) 9 (n = 52; 17.3%) 21 (20.6%)
 Some/limited understanding 19 (n = 50; 38%) 19 (n = 52; 36.5%) 38 (37.3%)
 No knowledge/understanding 19 (n = 50; 38%) 24 (n = 52; 46.2%) 43 (42.2%)
Sources of information (Q9)
 Hospital/GP leaflets 22 (n = 31; 71%) 18 (n = 27; 66.7%) 40 (69%)
 Discussion with clinical staff 15 (n = 31; 48.4%) 15 (n = 27; 55.6%) 30 (51.7%)
Best comparator to use (Q14)
 Natural background radiation 14 (n = 49; 28.6%) 8 (n = 51; 15.7%) 22 (22%)
 Chest X-rays 17 (n = 49; 34.7%) 10 (n = 51; 19.6%) 27 (27%)
 CT scans 4 (n = 49; 8.2%) 1 (n = 51; 2%) 5 (5%)
 Transatlantic flights 2 (n = 49; 4.1%) 9 (n = 51; 17.6%) 11 (11%)
 Not sure/other 12 (n = 49; 24.5%) 23 (n = 51; 45.1%) 35 (35%)
Received departmental leaflet (Q15)
 Yes 45 (n = 49; 91.8%) 41 (n = 49; 87.3%) 86 (n = 98; 87.8%)
 No 4 (n = 49; 8.2%) 8 (n = 49; 16.3% 12 (n = 98; 12.2%)
Provides enough information (Q16)
 Yes 39 (n = 44; 88.6%) 31 (n = 41; 75.6%) 70 (n = 85; 82.4%)
 No 5 (n = 44; 11.4%) 10 (n = 41; 24.4%) 15 (n = 85; 17.6%)
CT, computed tomography; FDG, fluoro-D-glucose.
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medical staff. The majority of patients 45/49 (91.8%) 
received the departmental leaflets and the majority 39/44 
(88.6%) agreed it provided enough information regarding 
doses of radiation used in nuclear medicine. Within G2 
11/52 (21.2%) patients answered correctly with 14/200 
(6.7%) correct answers, 55/200 (26.4%) incorrect answers 
and the vast majority answered, ‘I don’t know’ 139/200 
(66.8%). Patients who had previous scans gave more cor-
rect answers 8/31 (25.8%) when compared to patients 
who did not have previous scans, 3/21 (14.3%). The main 
sources of information for patients who answered cor-
rectly were hospital/GP leaflets, followed by discussion 
with medical staff and medical/science websites. The 
majority of patients from G2 received the departmental 
leaflets 41/49 (87.3%) and thought the leaflets provided 
enough information 31/41 (75.6%). Patients with higher 
educational status answered correctly to a higher number 
of questions, with 5 patients in G1 and 13 patients in G2.
Qualitative data
In total, there were 55 comments across the two ques-
tions, 10 relating to adequateness of the leaflet and 45 
relating to other issues, 14 comments were deemed not 
relevant, as these mainly addressed hospital facilities.
Data were reviewed twice, coded, and basic themes were 
further analysed and merged into higher themes: (a) ade-
quate information and (b) communication and trust in 
the clinical team. From these, the global theme: commu-
nication and information are essential to improve patient 
overall experience when undertaking a nuclear medicine 
diagnostic scan was identified.
Adequate information
Patients commented on the need for more information 
regarding ionising radiation used in diagnostic procedures 
using common comparators such as the ones used in the 
questionnaire. For example: ‘Leaflet doesn’t say much 
about the level of radiation at all’, with another patient’s 
comment ‘it is not just bone scans but other scans, X-rays, 
therapy that is relevant on a cumulative basis to an indi-
vidual measured against a “safe” dose.’
The information, however, must be meaningful to 
patients, ‘too much knowledge can frighten people…,’ 
‘reference to nuclear radiation is not likely to cause 
Fig. 1
Group comparison on awareness of radiation exposure.
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patients to feel confident in treatment being harmless,’ 
and ‘knowing a level is not really meaningful on its own.’ 
Some patients indicated that they would not require more 
information ‘I don’t believe I would benefit from a more 
detailed explanation of radiation doses. I would go ahead 
regardless as the scan is important for my treatment.’
Communication and trust in the clinical team
This was well illustrated by patients’ comments: ‘whilst 
more information is always useful I am happy to follow 
medical advice that a scan is necessary’; ‘I feel reassured 
by the verbal explanation from the staff’ and ‘I have com-
plete trust in the medical staff and assume the treatment 
they decide on is the best suited to my needs’; to ‘keep 
up the communication between patient and yourselves. 
It will continue to improve general understanding of 
issues.’
Global theme: communication and information 
are essential to improve patient overall experience 
when undertaking a nuclear medicine diagnostic 
scan Communication and information are two fun-
damental aspects expressed by patients, so that they 
are able to understand the procedures they have been 
referred for. While some patients would like to receive 
more information on radiation exposure derived not only 
from nuclear medicine scans but also from other imag-
ing procedures, for other patients complete trust in the 
health professionals means they do not necessarily appre-
ciate more information and for some unless it is meaning-
ful it can cause distress and fear.
Discussion
This study aimed to establish if patients understand how 
much radiation they are exposed to when they have a 
bone scan or a PET/CT with a view to modify existing 
patient leaflets. The quantitative results from the four 
questions on awareness of radiation exposure in section 
(c) include a low number of correct answers alongside a 
high number of ‘I don’t know,’ across both groups. These 
findings are in accordance with studies included in the 
literature review, all of which reported patients lack 
awareness and knowledge on ionising radiation exposure 
[15–17]. Similar findings were also reported in a recent 
mixed methods study comprising a survey and focus 
groups conducted in Spain aimed at evaluating general 
population understanding of the benefits and risks asso-
ciated with five imaging modalities (nuclear medicine 
not included) as well as their opinions on how that infor-
mation should be delivered [18]. Results demonstrated 
the general population lacked information concerning 
ionising radiation exposure from medical imaging and 
more information should be provided to patients to make 
them aware of the radiation exposure when undergo-
ing scans involving ionising radiation. A study in 2011 
by Freudenberg and Beyer[19] concluded that experts 
within nuclear medicine and radiology should aim to 
educate and inform not only patients but also referring 
clinicians who also lack knowledge.
The qualitative data, resulting from the two open-ended 
questions, however, highlights a mixed response. Some 
patients state they would not benefit from more detailed 
information and indicate that they trust the clinical team, 
whereas others suggest communication between health-
care professionals and patients should be encouraged. 
Patients also suggested incorporating more meaningful 
information on leaflets such as comparisons of risk and 
benefits of the associated exposures from the diagnos-
tic tests. This is particularly relevant since across both 
groups the majority of patients received information on 
radiation exposure from nuclear medicine imaging via 
hospital leaflets.
The results from section 3 of the questionnaire demon-
strate a low awareness of radiation exposure from diag-
nostic imaging when put side-to-side with common 
comparators. As this study illustrates, however, this might 
not be the correct way to present data to patients. Several 
comparators have historically been used to describe the 
dose of radiation and associated risks, such as natural 
background radiation, flights, other clinical risks, and rate 
of cancer[20] as a means to simplify and inform patients 
and public. However, on their own, they may not fully 
convey the information to the general population and 
the perception of risk is different among individuals, just 
as for each patient, the risk/benefit ratio will be differ-
ent. As per a patient comment, the comparison to a ‘safe 
dose’ is also important, as the exposure on its own can be 
meaningless.
The recent changes in the UK, with IRMER 2017, 
Schedule 2–Employers Procedures, state that patients 
must be informed ‘(i) providing that wherever practica-
ble, and prior to an exposure taking place, the patient or 
their representative is provided with adequate informa-
tion relating to the benefits and risks associated with the 
radiation dose from the exposure’ [3].
Imaging departments are required to provide clear informa-
tion about radiation exposure to patients, and there is the 
need for better communication about the risks and benefits 
to patients. Describing the benefits of having a particular 
scan/therapy that uses ionising radiation by demonstrating 
the potential risk of not having the scan/therapy is another 
possible way to convey information to patients and in some 
cases perhaps more meaningful [21,22].
Continuous professional education and development for 
health professionals are also essential to ensure the best 
care is provided and professionals are able to correctly 
inform patients and relatives [19,23–25]. A UK study of 
radiographers’ perspectives on CT risks and how infor-
mation is given to patients highlighted that radiographers 
often fail to communicate effectively with patients when 
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it comes to ionising radiation exposure. This was mainly 
due to the fear of discouraging patients from undergoing 
the scans, time constraints with busy clinics and a lack 
of knowledge on radiation exposure and how best to 
explain it [26]. To truly reflect a shared decision-making 
process where clinicians actively engage with patients for 
patient-centred care, it is crucial that healthcare profes-
sionals understand and are able to inform patients on the 
benefits and potential risks of ionising radiation for med-
ical purposes supported by best evidence-based practice 
and guidelines [19,24,27].
This study and questionnaire are based on the accepted 
linear no-threshold (LNT) model as the impact of alter-
native models remains unclear. LNT model has been in 
practice for the last 70 years, and it was introduced as a 
mean to simplify radiation protection [28]. It is based on 
the fact that any exposure to ionising radiation, including 
very low dose such as X-ray, can lead to carcinogenesis’s 
and the risk is proportional to the dose—that is, double 
the radiation exposure dose means double the risk.
Although there is a growing body of literature against the 
LNT, it remains the model underpinning current legisla-
tive frameworks and therefore was the basis for this study 
[29–31].
Recommendation for future research
Engaging with patient and public involvement and 
engagement in wider research to assess knowledge, 
develop, and promote education is essential to improve 
patient and public awareness and knowledge. Good 
communication between healthcare professionals and 
patients on ionising radiation has the ability to not only 
increase patient knowledge but also potentially reduce 
anxiety and empower patients to have confidence in their 
treatment decisions.
Conclusion
This study aimed to provide a current status of patient 
awareness in this particular clinical setting in view of cur-
rent legislation modifications with the revised IR(ME)R 
regulations and the need to better inform patients.
The quantitative results demonstrate limited patient 
awareness on radiation exposure. The qualitative results, 
however, indicate that this is not necessarily an important 
factor for patients themselves. Patients would welcome 
accurate and clear information they can easily understand 
regarding the risks and benefits derived from medical 
imaging in general.
In order to comply with recent changes in UK legislation 
with IR(ME)R 2017. It is crucial to develop communica-
tion guidelines in close collaboration with patients and 
public in order to provide patients with accurate informa-
tion that they can relate to and thus ensure the principle 
of informed consent is present.
Limitations
A review of existing validated questionnaires did not find 
a suitable tool. A questionnaire was developed solely for 
this study, and therefore, we do not recommend this to 
be used in other studies. We recommend that whenever 
possible a validated questionnaire is used.
The study involved a relatively small sample from a sin-
gle department, with no significances in the statistical 
tests performed and limited qualitative data. Although 
cautious interpretation is required when extrapolating 
the study results to a wider population or when identi-
fying potential factors that affect patient awareness and 
understanding, cross tabulation using frequencies and 
percentages is valid for the population in question, with 
results being similar to the studies included in literature 
review.
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